| Hans-Günter Meyer-Thompson | Gabapentinoide
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance.
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance.
Peckham AM, Ananickal MJ, Sclar DA.
Risk Manag Healthc Policy. 2018 Aug 17;11:109-116. doi: 10.2147/RMHP.S168504.